Compare · 3 funds side by side · dividends reinvested

XOVR, MDEV and VGT

XOVRER Shares×MDEVFirst Trust×VGTVanguard×

Story of the three · Growth5Y$10,000 five years agoDividends reinvested · all three on one scale$20,649VGT · best of the three

02 / 04

XOVR, MDEV and VGT, Ranked

Today

FundFeeYieldYTD1 year3 yrs · yr5 yrs · yrWorst dropVolatilityAssetsAvg rank

Vanguard Information Technology ETFSectors · Technology0.09%0.44%+15.6%+12.1%+28.6%+15.6%−17.5%26.5%$155B1.3

First Trust Indxx Medical Devices ETFSectors · Health care0.70%0.10%+7.9%+11.0%+9.0%−2.4%−18.2%17.4%$4M1.9

ERShares Private-Public Crossover ETFUnsorted0.75%0.00%−2.9%−6.5%[…][…]−21.6%26.0%$1.4B2.8

Rank among the three1st → 3rdFee, drop and volatility: lower ranks higherAvg rank: mean of the 8 ranks · 1 is best

End-of-day Nov 6, 2026 · returns include dividends · since: XOVR 2017 · MDEV 2021 · VGT 2004

Head to Head

Swap sides Versus in desk

Head to Head

ERShares Private-Public Crossover ETF · $1.4B[…]

XOVR

MDEV

First Trust Indxx Medical Devices ETF · $4M$8,839

$10,000 five years ago, dividends reinvested · they hold 4.0% in common

XOVRMeasureMDEV

−2.9%Year to dateJan 1 → Nov 6+7.9%

−6.5%1 yearTotal return+11.0%

[…]3 years · per year$10,000 became […] · $12,957+9.0%

[…]5 years · per year$10,000 became […] · $8,839−2.4%

0.75%Expense ratio$75 · $70 a year on $10k · lower is better0.70%

0.00%Trailing 12-mo yield$0 · $10 a year on $10k0.10%

−21.6%Worst dropSmaller is better−18.2%

26.0%VolatilityLower is calmer17.4%

XOVRMDEV Winner of the row, in its colourEach row: the bigger of the two fills its side

0–6MDEV wins

End-of-day Nov 6, 2026 · returns include dividends · 3Y and 5Y figures are per-year returns

More Ways to See the Pairs

XOVR vs MDEV: Top 5 Holdings

Today

XOVR

27.1%in top 5

MDEV

in top 511.4%

XOVRStockMDEV

8.5%NVDAnot top 5

5.5%GOOGLnot top 5

4.6%METAnot top 5

4.5%CARTnot top 5

4.1%TOSTnot top 5

not top 5GEHC2.4%

not top 5PHIA.AS2.3%

not top 5TFX2.3%

not top 5SYK2.2%

not top 5ZBH2.2%

Held in common4.0%

End-of-day Nov 6, 2026 · share of each fund

XOVR vs MDEV Returns, Every Period

ER SharesXOVR

−6.5%

past year

MDEVFirst Trust

+11.0%

past year

XOVRMDEVFaded: behind in that period

0–2MDEV wins

End-of-day Nov 6, 2026 · dividends in · faded = behind in that period

Unsorted vs Sector: XOVR vs VGT

YTD

ER SharesXOVR

−2.9%

VGTVanguard

+15.6%

−2.9%Year to date+15.6%

−21.6%Worst drop · 1Y−17.5%

26.0%Volatility · 1Y26.5%

0.0%Yield0.4%

$1.4BAssets$155B

3–1VGT wins

End-of-day Nov 6, 2026 · smaller drop and lower volatility win

Cost, Income and Risk

Fees: XOVR, MDEV, VGT

Today

0.09%lowest, VGT

FundExpense ratioFee$10k

VGT0.09%$9

MDEV0.70%$70

XOVR0.75%$75

End-of-day Nov 6, 2026 · fee on $10,000 a year

Yields: XOVR, MDEV, VGT

0.44%highest, VGT

FundTrailing yieldYield$10k

VGT0.44%$44

MDEV0.10%$10

XOVR0.00%$0

End-of-day Nov 6, 2026 · trailing 12-month yield

Income After Fees on $10,000

$35most kept, VGT

VGT$44 − $9 = $35

MDEV$10 − $70 = −$60

XOVR$0 − $75 = −$75

KeptFee

End-of-day Nov 6, 2026 · yield in dollars minus the fee

Overlap: XOVR, MDEV, VGT

Today

12.8%most shared, XOVR and VGT

XOVRMDEVVGT

XOVR—4.0%12.8%

MDEV4.0%—0.0%

VGT12.8%0.0%—

End-of-day Nov 6, 2026 · share held in common · outlined: the pair in versus

Return vs Bumpiness: 3 ETFs

+12.1%VGT, at 26.5% volatility

MDEVWorst drop−18.2%17.4% vol

XOVRWorst drop−21.6%26.0% vol

VGTWorst drop−17.5%26.5% vol

End-of-day Nov 6, 2026 · up and left is better

Paid More vs Made More

YTD

VGTMDEV

+15.6%Year to date+7.9%

0.4%Yield0.1%

+12.1%Past year+11.0%

0.09%Fee0.70%

4–0VGT wins

End-of-day Nov 6, 2026

Popular Pairs Near These Three

XLK vs VGT

YTD

SPDRXLK

+14.8%

VGTVanguard

+15.6%

+14.8%Year to date+15.6%

0.08% · $8Fee · on $10k a year0.09% · $9

$117BAssets$155B

1–1level

End-of-day Nov 6, 2026

SCHD vs VIG

YTD

SchwabSCHD

+31.4%

VIGVanguard

+12.1%

+31.4%Year to date+12.1%

3.0%Yield1.5%

$120BAssets$109B

2–0SCHD wins

End-of-day Nov 6, 2026

JEPQ vs JEPI

YTD

J.P. MorganJEPQ

+3.2%

JEPIJ.P. Morgan

+5.3%

+3.2%Year to date+5.3%

12.8%Yield8.1%

$42.6BAssets$46.8B

1–1level

End-of-day Nov 6, 2026